Common Contracts
3 similar Warrant Agreement contracts by Northwest Biotherapeutics Inc
NORTHWEST BIOTHERAPEUTICS, INC. FORM OF WARRANTWarrant Agreement • June 7th, 2007 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Certifies That, for value received, Toucan Partners, LLC, with its principal office at 7600 Wisconsin Avenue, Suite 700, Bethesda, MD 20814, and/or its assigns (collectively, the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office at 18701 120th Avenue NE, Suite 101, Bothell, Washington 98011 (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price (each subject to adjustment as provided herein). This Warrant is being issued pursuant to the terms of the Recapitalization Agreement, dated as of April 26, 2004, as amended and restated on July 30, 2004, and as further amended from time to time, by and among the Company and Toucan Capital Fund II, L.P. (the “Recapitalization Agreement”).
NORTHWEST BIOTHERAPEUTICS, INC. AMENDED AND RESTATED SERIES A PREFERRED STOCK WARRANTWarrant Agreement • June 7th, 2007 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Certifies That, for value received, Toucan Capital Fund II, L.P., with its principal office at 7600 Wisconsin Avenue, Suite 700, Bethesda, MD 20814, and/or its designees or assigns (collectively, the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office at 18701 120th Avenue NE, Suite 101, Bothell, Washington 98011 (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price (each subject to adjustment as provided herein). This Warrant is being amended and restated in its entirety as of June 1, 2007, and amends, restates and supersedes in full that certain Warrant No. PW-1 dated as of January 26, 2005 issued by the Company in favor of the Holder, which was issued pursuant to the terms of the Recapitalization Agreement, dated April 26, 2004, as amended and restated on July 30, 2004, and as further amended from time to time, by and among the Company and the Holder (the
NORTHWEST BIOTHERAPEUTICS, INC. WARRANTWarrant Agreement • May 3rd, 2007 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Certifies That, for value received, Toucan Partners, LLC, with its principal office at 7600 Wisconsin Avenue, Suite 700, Bethesda, MD 20814, and/or its assigns (collectively, the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office at 17801 120th Avenue NE, Suite 101, Bothell, Washington 98011 (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price (each subject to adjustment as provided herein). This Warrant is being issued pursuant to the terms of the Amended and Restated Recapitalization Agreement, dated July 30, 2004, as amended on October 22, 2004, November 10, 2004, December 27, 2004, January 26, 2005, April 12, 2005, May 13, 2005, June 16, 2005, July 26, 2005, September 7, 2005 and November 14, 2005, by and among the Company and Toucan Capital Fund II, L.P. (the “Recapitalization Agreement”).
